Tag: low-cost pneumococcal vaccine
SA biotech firm wins State Government grant to trial low-cost pneumococcal vaccine
South Australian biotech company GPN Vaccines has secured a $1 million State Government grant to complete its first-in-human clinical trials for a more effective and lower...
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
